Sotabase

Career

· Researcher (Cognitive Robotics Group), University of Toronto2024–
· Ph.D. student in Artificial Intelligence (Computer Science), University of Toronto, Cognitive Robotics Group2004–2009

Publications (93)

Quantitative ChIP-Seq normalization reveals global modulation of the epigenome.
Cell Reports · 2014
472
cited
Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer.
Journal of Clinical Oncology · 2010
346
cited
A human nucleoporin-like protein that specifically interacts with HIV Rev
Nature · 1995
277
cited
PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models.
Chemistry and Biology · 2013
248
cited
Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy.
Current Opinion in Chemical Biology · 2010
190
cited
Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice
Molecular Microbiology · 2000
167
cited
The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models
Oncogene · 2011
160
cited
HIV Rev uses a conserved cellular protein export pathway for the nucleocytoplasmic transport of viral RNAs
Current Biology · 1996
118
cited
Dependence of Mycobacterium bovis BCG on Anaerobic Nitrate Reductase for Persistence Is Tissue Specific
Infection and Immunity · 2002
111
cited
Planning with Qualitative Temporal Preferences
International Conference on Principles of Knowledge Representation and Reasoning · 2006
109
cited
Therapeutic Targeting of a Robust Non-Oncogene Addiction to PRKDC in ATM-Defective Tumors
Science Translational Medicine · 2013
101
cited
Virulence of Agrobacterium tumefaciens requires phosphatidylcholine in the bacterial membrane
Molecular Microbiology · 2006
86
cited
Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer
Molecular Cancer Therapeutics · 2008
80
cited
Exploiting Procedural Domain Control Knowledge in State-of-the-Art Planners
International Conference on Automated Planning and Scheduling · 2007
80
cited
Monitoring Plan Optimality During Execution
International Conference on Automated Planning and Scheduling · 2007
75
cited
LYMPHOID NEOPLASIA B-cell – speci fi c conditional expression of Myd88 p.L252P leads to the development of diffuse large B-cell lymphoma in mice by Sequencing Project
2016
73
cited
Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors.
Journal of Medicinal Chemistry · 2012
71
cited
IPI-504, a novel and soluble HSP-90 inhibitor, blocks the unfolded protein response in multiple myeloma cells
Cancer Chemotherapy and Pharmacology · 2008
67
cited
Using Golog for Deliberation and Team Coordination in Robotic Soccer
Künstliche Intell. · 2005
58
cited
A point mutation in the chloroplast 16 S rRNA gene of a streptomycin resistant Nicotiana tabacum
1987
57
cited
Sotabase
Christian Fritz | Researcher Profile | Sotabase | Sotabase